Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

VVOSBullishCorporate Developmentsnews

High materiality8/10

Vivos Partners With SPCVA to Launch Florida Sleep and Airway Center

Aug 28, 2026, 8:47 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Direct, multi-piece collaboration with a sizable referral base and a defined near-term revenue timeline could re-rate VVOS on execution success and TAM expansion; however, real revenue impact hinges on site leasing, payer enrollment, and patient uptake by 2027.

AI summary

What happened, with direct paths to the underlying reporting

Vivos Therapeutics announced definitive collaboration and operating agreements with South Palm Cardiovascular Associates to launch a regional Sleep & Airway Medicine Center in Palm Beach County, via AIM Florida LLC with Vivos owning 75%. The center could begin treating patients in Q1 2027, with an initial Sleep Optimization Team serving about 250 patients per month and potential annual revenue up to $6 million with 30%+ margins. This expands access to FDA-cleared Vivos CARE therapies within a scalable model, potentially boosting VVOS adoption and revenue over the next 12–18 months.

Vivos and SPCVA finalize agreements to launch SAMC in Palm Beach County.
AIM Florida to hold 75% ownership; revenue start anticipated in 2027.
Sleep Optimization Team aims for ~250 patients/month; up to $6M annual revenue.
Vivos CARE devices FDA-cleared; multiple treatment options to be offered at SAMC.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.